| BE0336-100MG
| InVivoMAb anti-human MUC1 (CD227)
| 100 mg
| BioXCell
| in vivo administration in mouse xenograft models,
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0368-1MG
| InVivoMAb anti-human/mouse/rat amyloid-beta
| 1 mg
| BioXCell
| Western blot, Immunohistochemistry, Immunofluoresc
|
| Mouse
| Human, Mouse, Rat
| Solicitar Precio
| Solicitar
|
| BE0322-50MG
| InVivoMAb anti-mouse CD172a (SIRP?)
| 50 mg
| BioXCell
| in vivo SIRP? blocking, In vitro SIRP? blocking, W
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0357-5MG
| InVivoMAb anti-SARS-CoV-2 S protein (RBD epitope A)
| 5 mg
| BioXCell
| in vitro blocking of SARS-CoV-2 S protein, Flow cy
|
| Mouse
| Virus
| Solicitar Precio
| Solicitar
|
| BE0347-1MG
| InVivoMAb anti-human CSF1R (CD115)
| 1 mg
| BioXCell
| in vitro CSF1R neutralization, Immunohistochemistr
|
| Rat
| Human
| Solicitar Precio
| Solicitar
|
| BE0360-100MG
| InVivoMAb anti-mouse CD24
| 100 mg
| BioXCell
| in vivo administration, Immunohistochemistry (froz
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0359-25MG
| InVivoMAb anti-SARS-CoV-2 S protein (RBD epitope B)
| 25 mg
| BioXCell
| in vitro blocking of SARS-CoV-2 S protein, Flow cy
|
| Mouse
| Virus
| Solicitar Precio
| Solicitar
|
| BE0345-1MG
| InVivoMAb anti-mouse/rat/bovine VLDL-R
| 1 mg
| BioXCell
| Western blot
|
| Mouse
| Goat, Mouse, Rat
| Solicitar Precio
| Solicitar
|
| BE0357-25MG
| InVivoMAb anti-SARS-CoV-2 S protein (RBD epitope A)
| 25 mg
| BioXCell
| in vitro blocking of SARS-CoV-2 S protein, Flow cy
|
| Mouse
| Virus
| Solicitar Precio
| Solicitar
|
| BE0371-5MG
| InVivoMAb anti-mouse IL-12 p35
| 5 mg
| BioXCell
| in vivo IL-12 p35 neutralization, in vitro IL-12 p
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0373-25MG
| InVivoMAb anti-mouse osteopontin (SPP1)
| 25 mg
| BioXCell
| in vivo OPN neutralization, in vitro OPN neutraliz
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0331-50MG
| InVivoMAb anti-rat/mouse CD71 (TfR1)
| 50 mg
| BioXCell
| Targeted drug delivery to the brain, Immunohistoch
|
| Mouse
| Mouse, Rat
| Solicitar Precio
| Solicitar
|
| BE0358-5MG
| InVivoMAb anti-SARS-CoV-2 S protein (NTD)
| 5 mg
| BioXCell
| Flow cytometry, ELISA
|
| Mouse
| Virus
| Solicitar Precio
| Solicitar
|
| BE0329-50MG
| InVivoMAb anti-mouse CD71 (TfR1)
| 50 mg
| BioXCell
| in vivo depletion of CD71+ cells, Immunofluorescen
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0317-100MG
| InVivoMAb anti-mouse CD38
| 100 mg
| BioXCell
| in vivo CD38 stimulation, in vitro CD38 stimulatio
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0366-1MG
| InVivoMAb mouse IgG2c isotype control, anti-dengue virus
| 1 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BE0318-1MG
| InVivoMAb anti-human Ganglioside GD2
| 1 mg
| BioXCell
| in vitro induction of apoptosis in GD2+ cells, in
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0363-25MG
| InVivoMAb anti-human CEACAM7
| 25 mg
| BioXCell
| Western blot*, ELISA*, Immunoprecipitation*, Immun
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0364-100MG
| InVivoMAb anti-mouse BTLA (CD272)
| 100 mg
| BioXCell
| in vivo BTLA blockade, Flow cytometry
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0347-50MG
| InVivoMAb anti-human CSF1R (CD115)
| 50 mg
| BioXCell
| in vitro CSF1R neutralization, Immunohistochemistr
|
| Rat
| Human
| Solicitar Precio
| Solicitar
|
| BE0370-1MG
| InVivoMAb anti-human CD71 (TfR1)
| 1 mg
| BioXCell
| Flow cytometry, Immunoprecipitation
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0332-1MG
| InVivoMAb anti-mouse FGL-1
| 1 mg
| BioXCell
| in vivo FGL-1 blockade, in vitro FGL-1 blockade, F
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0320-5MG
| InVivoMAb anti-mouse Ly6G/Ly6C
| 5 mg
| BioXCell
| in vivo neutrophil depletion, Immunohistochemistry
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0340-25MG
| InVivoMAb anti-human/monkey MDR-1 (CD243)
| 25 mg
| BioXCell
| in vivo MDR-1 blocking/depletion in xenogeneic mur
|
| Mouse
| Human, Monkey
| Solicitar Precio
| Solicitar
|
| BE0321-5MG
| InVivoMAb anti-mouse NKG2A/C/E
| 5 mg
| BioXCell
| in vivo NKG2A blockade (see description), in vitro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0362-50MG
| InVivoMAb anti-human CEACAM 1/3/5/6/8
| 50 mg
| BioXCell
| Western blot, ELISA, Immunofluorescence, Immunohis
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0364-5MG
| InVivoMAb anti-mouse BTLA (CD272)
| 5 mg
| BioXCell
| in vivo BTLA blockade, Flow cytometry
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0302-25MG
| InVivoMAb anti-mouse CD20
| 25 mg
| BioXCell
| Flow cytometry, Western blot, Not recommended for
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0298-100MG
| InVivoMAb anti-mouse CD122 (IL-2R?)
| 100 mg
| BioXCell
| in vivo NK cell depletion, in vivo CD122 blockade,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0363-1MG
| InVivoMAb anti-human CEACAM7
| 1 mg
| BioXCell
| Western blot*, ELISA*, Immunoprecipitation*, Immun
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0341-50MG
| InVivoMAb anti-human EphA2
| 50 mg
| BioXCell
| Immunohistochemistry (paraffin), Immunoprecipitati
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0368-50MG
| InVivoMAb anti-human/mouse/rat amyloid-beta
| 50 mg
| BioXCell
| Western blot, Immunohistochemistry, Immunofluoresc
|
| Mouse
| Human, Mouse, Rat
| Solicitar Precio
| Solicitar
|
| BE0327-5MG
| InVivoMAb anti-human IL-9
| 5 mg
| BioXCell
| Flow cytometry, ELISA
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0333-50MG
| InVivoMAb anti-mouse/human/rat LRP1 (CD91)
| 50 mg
| BioXCell
| Western blot, Immunofluorescence, Immunoprecipitat
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BE0321-1MG
| InVivoMAb anti-mouse NKG2A/C/E
| 1 mg
| BioXCell
| in vivo NKG2A blockade (see description), in vitro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0339-100MG
| InVivoMAb anti-mouse NKG2AB6
| 100 mg
| BioXCell
| Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0309-25MG
| InVivoMAb anti-mouse CXCL9 (MIG)
| 25 mg
| BioXCell
| in vivo CXCL9 neutralization, Immunofluorescence
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0321-100MG
| InVivoMAb anti-mouse NKG2A/C/E
| 100 mg
| BioXCell
| in vivo NKG2A blockade (see description), in vitro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0298-25MG
| InVivoMAb anti-mouse CD122 (IL-2R?)
| 25 mg
| BioXCell
| in vivo NK cell depletion, in vivo CD122 blockade,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0328-50MG
| InVivoMAb anti-mouse CD28
| 50 mg
| BioXCell
| in vivo T cell stimulation/activation, in vitro T
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0372-5MG
| InVivoMAb anti-mouse osteopontin (SPP1)
| 5 mg
| BioXCell
| in vivo OPN neutralization, in vitro OPN neutraliz
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0360-5MG
| InVivoMAb anti-mouse CD24
| 5 mg
| BioXCell
| in vivo administration, Immunohistochemistry (froz
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0351-5MG
| InVivoMAb anti-human NKG2D (CD314)
| 5 mg
| BioXCell
| in vitro NKG2D blocking, Immunoprecipitation, Flow
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0372-1MG
| InVivoMAb anti-mouse osteopontin (SPP1)
| 1 mg
| BioXCell
| in vivo OPN neutralization, in vitro OPN neutraliz
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0352-50MG
| InVivoMAb anti-mouse E-Cadherin (CD324)
| 50 mg
| BioXCell
| in vivo E-Cadherin neutralization, In vitro E-Cadh
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0346-100MG
| InVivoMAb anti-mouse CD326 (EpCAM)
| 100 mg
| BioXCell
| Immunohistochemistry (frozen), Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0304-1MG
| InVivoMAb anti-mouse BTLA (CD272)
| 1 mg
| BioXCell
| in vivo BTLA+ B cell and CD4 T cell depletion*, Fl
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0314-1MG
| InVivoMAb anti-mouse TIM-1 (CD365)
| 1 mg
| BioXCell
| in vivo TIM-1 blockade, in vitro TIM-1 blockade
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0312-50MG
| InVivoMAb anti-mouse IFN?
| 50 mg
| BioXCell
| in vivo IFN? neutralization, in vitro IFN? neutral
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0353-5MG
| InVivoMAb anti-mouse/human/rat/monkey ICOS (CD278)
| 5 mg
| BioXCell
| in vitro T cell stimulation/activation, Flow cytom
|
| Armenian Hamster
| Human, Monkey, Mouse, Rat
| Solicitar Precio
| Solicitar
|